Methods, systems, and apparatus for reducing frequency and / or severity of photophobic responses or for modulating circadian cycles

JP2023166537A5Pending Publication Date: 2025-10-07UNIV OF UTAH RES FOUND
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
JP2023146670
Authority / Receiving Office
JP · JP
Patent Type
Applications
Current Assignee / Owner
Priority Date
2014-07-22
Filing Date
2023-09-11
Publication Date
2025-10-07

AI Technical Summary

Benefits of technology

についての説明は、共に全体が参照により本明細書に組み込まれる、Goodらの、The Use of Tinted Glasses in Childhood Migraine(小児偏頭痛における着色ガラスの使用)、Headache.1991年9月;31(8):533-6PMID1960058と、Blackburnらの、FL-41 Tint Improves Blink Frequency Light Sensitivity and Functional Limitations in Patients with Benign Essential Blepharospasm(FL-41着色が良性特発性眼瞼痙攣の患者のまばたき頻度光過敏症と機能制限とを改善)、Ophthalmology.2009年5月;116(5):997-1001 PMID19410958とから理解され得る。メラノプシン神経節細胞は、痛みの伝達経路に加えて視交叉上核にも結合しており、視交叉上核においてメラノプシン神経節細胞が概日リズムの同調に関与する。これらの結合は、全体が参照により本明細書に組み込まれる、Hannibal J.の、Roles of PACAP-containing retinal ganglion cells in circadian timing(概日タイミングにおけるPACAP含有網膜神経節細胞の役割)、Int Rev Cytol.2006;251:1-39.Review.PubMed PMID:16939776により詳しく説明されている。

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 00000000_0001_ABST
    Figure 00000000_0001_ABST
  • Figure 00000000_0000_ABST
    Figure 00000000_0000_ABST
Patent Text Reader

Abstract

To provide an optical filter which may reduce the frequency and / or severity of photophobic responses or for modulating circadian cycles by controlling light exposure to cells in the human eye in certain wavelengths, such as 480 nm and 590 nm, and a visual spectral response of the human eye, the optical filter which may disrupt the isomerization of melanopsin in the human eye reducing the availability of the active isoform, whereas the attenuation of light weighted across the action potential spectrum of the active isoform attenuates the phototransduction cascade leading to photophobic responses.SOLUTION: Embodiments of an optical filter are described. In one embodiment, an optical filter may be configured to transmit less than a first amount of light in certain wavelengths, and to transmit more than a second amount of light weighted across the visual spectral response. Methods of use and methods of manufacturing optical filters are also described.SELECTED DRAWING: Figure 26
Need to check novelty before this filing date? Find Prior Art

Claims

1. 1. A device for reducing the frequency and / or severity of photophobia by controlling light exposure to melanopsin ganglion cells in the cornea for wavelengths in the visible spectral range of 400 nm to 700 nm, comprising: Equipped with an optical filter, The optical filter is configured to transmit less than a first amount of light averaged over wavelengths between about 454 nm and about 506 nm and greater than a second amount of light averaged over wavelengths in the visible spectrum less than about 454 nm and greater than about 506 nm, the first amount of light being less than the amount of light received by melanopsin ganglion cells of the subject (D melan ) and the second amount of light is a visible response spectrum (D vis ), wherein a ratio including the first amount of light and the second amount of light is defined as a figure of merit (FOM), and the figure of merit is: [Equation 17] is determined by D melan (T=1) is the first light amount when there is no optical filter, and D vis (T=1) is the second amount of light without an optical filter, and the figure of merit of the optical filter is at least 1.

3.

2. 10. The apparatus of claim 1, the first light amount is 55% and the second light amount is 70%; the first light amount is 65% and the second light amount is 80%; the first light amount is 35% and the second light amount is 50%; the first light amount is 25% and the second light amount is 40%; the first light amount is 45% and the second light amount is 60%; the first light amount is 15% and the second light amount is 30%; the first amount of light is 10% and the second amount of light is 20%; or The apparatus, wherein the first amount of light is 5% and the second amount of light is 10%.

3. 10. The apparatus of claim 1, wherein the optical filter comprises one or more of a color filter or a tint.

4. 10. The apparatus of claim 1, wherein the figure of merit of the optical filter is at least 1.

5.

5. 10. The apparatus of claim 1, the optical filter is further configured to reflect a third amount of light averaged over wavelengths between about 454 nm and about 506 nm from a back side of the optical filter, the third amount of light being less than about 50% of the light incident on the back side.

6. 10. The apparatus of claim 1, wherein the filter comprises a multilayer dielectric, a nanoparticle buried coating, a resonant guided mode filter, or a rugate filter.

7. 1. A system for reducing the frequency and / or severity of photophobia by controlling the exposure of melanopsin ganglion cells in the cornea to light within the visible spectral range of 400 nm to 700 nm wavelengths, comprising: A substrate; a first layer disposed on the substrate, the first layer comprising a high refractive index material; a second layer disposed adjacent to the first layer, the second layer comprising a low refractive index material; A system comprising:

8. 8. The system of claim 7, The high refractive index material of the first layer is TiO 2 and The low refractive index material of the second layer is SiO 2 and TiO 2 and SiO 2 and one or more additional alternating adjacent layers of a first additional layer adjacent to the second layer; The final additional layer is MgF 2 , SiO 2 or TiO 2 and adjacent to the outer layer of the system.

9. 8. The system of claim 7, The system, wherein the optical filter is a notch filter comprising 10 dielectric layers, and the notch filter is configured to block approximately 61% of light weighted across the action potential spectrum of the melanopsin ganglion cells and cause an attenuation of approximately 21% weighted across the visible spectral response.

10. 8. The system of claim 7, The system, wherein the optical filter is a notch filter comprising 15 dielectric layers, and the notch filter is configured to block approximately 70% of light weighted across the action potential spectrum of the melanopsin ganglion cells and cause approximately 25% attenuation weighted across the visible spectral response.

11. 8. The system of claim 7, The system, wherein the optical filter is a notch filter comprising 19 dielectric layers, and the notch filter is configured to block approximately 89% of light weighted across the action potential spectrum of the melanopsin ganglion cells and cause an attenuation of approximately 29% weighted across the visible spectral response.

12. 8. The system of claim 7, The system, wherein the substrate further comprises a first side, the first layer applied to the first side, and an anti-reflective coating applied to a side of the substrate opposite the first side.

13. 1. A device for reducing the frequency and / or severity of photophobia or regulating circadian rhythm by controlling exposure of cells in the cornea to wavelengths in the visible spectral range of 400 nm to 700 nm, comprising: Equipped with an optical filter, The optical filter is Light averaged over a first wavelength range between about 565 nm and about 615 nm is transmitted, and the light transmitted over the first wavelength range is measured as the amount of light received by receptor cells in the subject (D rec,590 ) and and transmitting light averaged over a second wavelength range between about 454 nm and about 506 nm, the light transmitted over said second wavelength range being a measure of the amount of light received by receptor cells in the subject (D melan ) and transmits light averaged over a third wavelength range within the visible spectrum below about 454 nm, between about 506 nm and about 565 nm, and above about 615 nm, wherein the light transmitted over the third wavelength range is a function of the amount of light received over the visible spectrum (D vis ) and The ratio of the light over the first wavelength range to the light over the third wavelength range is defined as a figure of merit (FOM) of the optical filter, the figure of merit being: [Equation 18] is determined by D rec,590 (T=1) is light over the first wavelength range in the absence of an optical filter, and D vis (T=1) is light over the third wavelength range in the absence of an optical filter, and the figure of merit is at least 1.3; The ratio of the light over the second wavelength range to the light over the third wavelength range is defined as a figure of merit (FOM) of the optical filter, the figure of merit being: [Equation 19] is determined by D melan (T=1) is light over the second wavelength range in the absence of an optical filter, and D vis (T=1) is light over said third wavelength range in the absence of an optical filter, and said figure of merit is at least 1.

3.

14. 1. A device for reducing the frequency and / or severity of photophobia by controlling light exposure to melanopsin ganglion cells in the cornea for wavelengths in the visible spectral range of 400 nm to 700 nm, comprising: an optical filter, the optical filter comprising: Light amount T melan an optical transmittance averaged over wavelengths between about 454 nm and about 506 nm of less than Light amount T vis a light transmittance averaged over wavelengths in the visible spectrum below about 454 nm and above about 506 nm that is greater than and The ratio including the light transmittance is defined as a figure of merit (FOM) of the optical filter, the figure of merit being: [Equation 20] is determined by The apparatus, wherein the figure of merit of the optical filter is at least 1.6.